
Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study
Keywords: AE; adverse event; ALS; antibodies in lymphocyte supernatants assay; ASC; antibody secreting cell; CF; colonization factor; CT; cholera toxin; CTB; cholera toxin binding subunit; dmLT; double mutant LT; ETEC; enterotoxigenic Escherichia coli; GM; geometri